| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6056926 Invention relates to the field of chemical synthesizers. |
| 05/02/2000 | CA2224616C Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2012480C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15 |
| 05/02/2000 | CA1340978C Purification, cloning and characterization of the gene for interleukin 1 |
| 04/27/2000 | WO2000023803A1 Methods of making patterned arrays of analyte-binding molecules |
| 04/27/2000 | WO2000023580A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | WO2000023545A1 Process for separating lipids and proteins from biological material |
| 04/27/2000 | WO2000023474A1 Protein engineering |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | DE19940752A1 Use of an illumination matrix that can be controlled to generate a freely adjustable illumination pattern to produce a microchip |
| 04/27/2000 | CA2633345A1 A method of affinity separation and ligands for use therein |
| 04/27/2000 | CA2347917A1 Protein engineering |
| 04/27/2000 | CA2347125A1 Methods of making patterned arrays of analyte-binding molecules |
| 04/26/2000 | EP0995755A1 Prodrugs of Thrombin inhibitors |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0994722A1 Method of removing endotoxin from vaccines |
| 04/26/2000 | EP0832130B1 Separating polymerized from unpolymerized hemoglobin using hydroxyapatite |
| 04/26/2000 | EP0832108B1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/26/2000 | EP0736102B1 Method for preparing peptide products |
| 04/26/2000 | EP0683790B1 Automated synthesis of oligonucleotides |
| 04/26/2000 | CN1251593A Selection of proteins using RNA-protein fusions |
| 04/25/2000 | US6054593 Elastase inhibitor |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054132 A purified toxin in diagnostic testing for detecting peptic ulceration and gastric malignancy, and as a vaccine for providing immunologic protection against bacterial infection |
| 04/25/2000 | US6054034 Acrylic inner surfaces give rise to substantially reduced electroosmotic flow and/or adsorption under conditions of electrophoresis, as compared to native fused silica |
| 04/25/2000 | CA2106079C Pegylation of polypeptides |
| 04/25/2000 | CA1340977C Scavenger receptor protein and antibody thereto |
| 04/25/2000 | CA1340972C Follistatin and method of purifying same |
| 04/20/2000 | WO2000022119A1 METHOD FOR OBTAINING ACTIVE β-NGF |
| 04/20/2000 | WO2000021982A1 A process for the preparation of a thrombus imaging agent |
| 04/20/2000 | WO2000021658A2 Porous device |
| 04/20/2000 | WO2000005243A3 Resin derivatization method and uses thereof |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | WO1999061653A3 Light-mediated regional analysis of biologic material |
| 04/20/2000 | WO1999058947A9 Modulation of molecular interaction sites on rna and other biomolecules |
| 04/20/2000 | DE19846011A1 Purification of granulocyte preparations useful for transfusion comprises removing nonfunctional granulocytes |
| 04/20/2000 | CA2347171A1 Porous device |
| 04/20/2000 | CA2341975A1 A process for the preparation of a thrombus imaging agent |
| 04/19/2000 | EP0994188A1 Method for obtaining active beta-NGF |
| 04/19/2000 | EP0994120A1 Process to remove lipopolysaccharides from aqueous solution of proteins |
| 04/19/2000 | EP0823056A4 Method of carboxy terminal protein or peptide sequencing |
| 04/19/2000 | EP0550561B1 Purification of cytokeratin fragments |
| 04/19/2000 | CN1250780A Shark liver irritant for preventing and curing hepatism and its preparing process |
| 04/18/2000 | US6051694 Mixing solid protein and a critical fluid in which the protein is insoluble, then rapid depressurization of mixture; product is active but solvent/salt/surfactant-free; for time-released drug delivery |
| 04/18/2000 | US6051687 Adding calcium ions to precipitate sulfite and sulfate, then removing precipitate; for feeds |
| 04/18/2000 | US6051686 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051399 Production of C-terminal amidated peptides from recombinant protein constructs |
| 04/18/2000 | US6051380 Hybridizing dna in an electrophoresis system using a low conductivity, zwitterionic buffer; transporting dna toward a microlocation where ph of buffer is below the isoelectric point, enhancing hybridization of dna to probe |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | CA2192184C Extraction of heterologous insoluble proteins from bacteria |
| 04/13/2000 | WO2000020870A1 Characterising polypeptides through cleavage and mass spectrometry |
| 04/13/2000 | WO2000020835A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | WO2000020459A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 04/13/2000 | WO2000020439A1 Process for eliminating n-terminal methionine |
| 04/13/2000 | WO2000020112A2 Chemical constructs and their uses |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000019884A1 Apparatus for examining a patient by means of light |
| 04/13/2000 | DE19844988A1 Parallele Festphasensynthese Parallel solid phase synthesis |
| 04/13/2000 | DE19830989C1 Verwendung von porösen Membranmaterialien als Beladungsmaterialien bei der Gelelektrophorese Use of porous membrane materials as loading materials on gel electrophoresis |
| 04/13/2000 | CA2346064A1 Method for removing n-terminal methionine |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2342606A1 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | CA2340333A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0991666A1 Alpha 1-antitrypsin preparation and method for the production thereof |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0909176A4 Reactor and method for solid phase peptide synthesis |
| 04/12/2000 | CN1051317C Displacement chromatography process and purified hemoglobin product |
| 04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
| 04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
| 04/11/2000 | US6048889 Proline derivatives |
| 04/11/2000 | US6048720 Conjugates of a polypeptide and a biocompatible polymer |
| 04/11/2000 | US6048715 Two-phase partition affinity separation system and affinity separated cell-containing composition |
| 04/11/2000 | US6048700 Detecting the presence of a bordetella antigen in a sample; contacting an antibody specific antigen with said sample and detecting binding of an antibody to bordetta antigen, binding of the antbody is an indicator of presence of antigen |
| 04/11/2000 | US6048690 Methods for electronic fluorescent perturbation for analysis and electronic perturbation catalysis for synthesis |
| 04/11/2000 | CA2220729C Method for refolding insoluble aggregates of hepatitis c virus protease |
| 04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA2009946C Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof |
| 04/11/2000 | CA2009579C Insulin analogs |
| 04/11/2000 | CA1340958C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/11/2000 | CA1340956C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
| 04/06/2000 | WO2000018904A2 Secreted proteins and nucleic acids encoding them |
| 04/06/2000 | WO2000018881A2 Intein mediated peptide ligation |
| 04/06/2000 | WO2000018823A2 Peg-based macromonomers, chemically inert polymers prepared therefrom and the use of these polymers for organic synthesis and enzyme reactions |
| 04/06/2000 | WO2000018792A1 Solid phase synthesis, whereby the solid phase consists of two different substrates |
| 04/06/2000 | WO2000018791A1 Ligand presenting assembly (lpa), method of preparation and uses thereof |
| 04/06/2000 | WO2000018790A1 Synthesis of cyclic peptides |
| 04/06/2000 | WO2000018789A1 Auxiliary for amide bond formation |
| 04/06/2000 | WO2000018503A2 Combinatorial synthesiser |
| 04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
| 04/06/2000 | WO1999062933A3 Rationally designed peptides, production and use thereof |